8 companies

WuXi XDC Cayman

Market Cap: HK$69.4b

An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.

New

2268

HK$57.65

7D

-6.9%

1Y

213.0%

Everest Medicines

Market Cap: HK$24.6b

A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.

New

1952

HK$70.15

7D

0.3%

1Y

279.2%

CanSino Biologics

Market Cap: HK$16.6b

Develops, manufactures, and commercializes vaccines in the People’s Republic of China.

New

6185

HK$47.42

7D

-3.5%

1Y

166.1%

Cutia Therapeutics

Market Cap: HK$2.9b

An investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People’s Republic of China and Hong Kong.

2487

HK$9.24

7D

7.6%

1Y

-2.1%

JBM (Healthcare)

Market Cap: HK$2.5b

An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.

2161

HK$3.07

7D

7.0%

1Y

248.9%

Innovent Biologics

Market Cap: HK$162.1b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.

1801

HK$94.65

7D

-0.4%

1Y

117.8%

Essex Bio-Technology

Market Cap: HK$3.2b

An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.

1061

HK$5.72

7D

5.3%

1Y

131.6%

Frontage Holdings

Market Cap: HK$3.0b

A contract research organization, provides laboratory and related services to pharmaceutical, biotechnology, and agrochemical companies.

1521

HK$1.50

7D

-3.8%

1Y

123.9%